Sign inJoin waitlistJoin the waitlist

Rachael Safyan

Medical Director, Hepatic Artery Infusion Pump Program, Fred Hutch/UW Medicine · University of Washington School of Medicine

Credentials: · · · · ·

History

Hepatic Artery Infusion Pump Program · University of Washington School of Medicine
Present
Clinical Research GI Oncology Program · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Hematology and Medical Oncology
Columbia University
2017–2020
Internal Medicine
University of Washington School of Medicine
2014–2017
Internal Medicine
Boston Medical Center
2011–2014
New York University Grossman School of Medicine
2007–2011
Barnard College of Columbia University
2003–2007

Research

BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
Review · Cancer Management and Research · 2020 · 83 citations
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Review · Current Cancer Drug Targets · 2017 · 63 citations
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
Review · The Lancet. Gastroenterology & hepatology · 2022 · 23 citations

EC
Elena Chiorean
11 papers
David Zhen
5 papers
Andrew Coveler
4 papers
Gentry King
4 papers
Gulam Manji
4 papers
Stacey Cohen
3 papers
Susan Bates
3 papers
Veena Shankaran
3 papers
William Harris
3 papers
Colin Pritchard
2 papers
Eric Konnick
2 papers
Paul Oberstein
2 papers

Clinical trials

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Principal investigator · Recruiting · Phase 3
SWOG Cancer Research Network
2026–2030
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
Principal investigator · Recruiting · Phase 1
Fred Hutchinson Cancer Center
2023–2028
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Principal investigator · Terminated · Phase 1
Fred Hutchinson Cancer Center
2021–2025